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Introduction: Despite studies demonstrating benefit, patients with femoral vascular catheters placed for
continuous renal replacement therapy are frequently restricted from mobilization. No researchers have reported
filter pressures during mobilization, and it is unknown whether mobilization is safe or affects filter lifespan. Our
objective in this study was to test the safety and feasibility of mobilization in this population.
Methods: A total of 33 patients undergoing continuous renal replacement therapy via femoral, subclavian or
internal jugular vascular access catheters at two general medical-surgical intensive care units in Australia were
enrolled. Patients underwent one of three levels of mobilization intervention as appropriate: (1) passive bed
exercises, (2) sitting on the bed edge or (3) standing and/or marching. Catheter dislodgement, haematoma and
bleeding during and following interventions were evaluated. Filter pressure parameters and lifespan (hours), nursing
workload and concern were also measured.
Results: No episodes of filter occlusion or failure occurred during any of the interventions. No adverse events were
detected. The intervention filters lasted longer than the nonintervention filters (regression coefficient = 13.8 (robust
95% confidence interval (CI) = 5.0 to 22.6), P = 0.003). In sensitivity analyses, we found that filter life was longer in
patients who had more position changes (regression coefficient = 2.0 (robust 95% CI = 0.6 to 3.5), P = 0.007). The
nursing workloads between the intervention shift and the following shift were similar.
Conclusions: Mobilization during renal replacement therapy via a vascular catheter in patients who are critically ill
is safe and may increase filter life. These findings have significant implications for the current mobility restrictions
imposed on patients with femoral vascular catheters for renal replacement therapy.
Trial registration: Australian and New Zealand Clinical Trials Registry ACTRN12611000733976 (registered 13 July 2011)Introduction
Acute renal failure occurs in 5.5% to 6.0% of patients
admitted to the intensive care unit (ICU), with almost
three-fourths of these patients requiring the institution
of continuous renal replacement therapy (CRRT) via
temporary double-lumen vascular catheters [1]. Historic-
ally, patients with femoral vascular catheters have been
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unless otherwise stated.infection and thrombosis [4]. Patient movement may alter
fluid dynamics, pressures and blood flow of the CRRT
circuit [5]. In contrast, immobilization protocols may
increase the risk of thrombosis and embolism [6]. Early
mobilization in the ICU is generally safe [7] on the basis
of an increasing evidence base [8-12]; in the context of
evolved understanding of post-ICU syndrome [13-16],
however, there are still specific clinical scenarios in which
the safety and feasibility of mobilization has not been
established. Moreover, CRRT is frequently present (in up
to 9% of sessions) [3] in patients most likely to benefit (for
example, those on mechanical ventilation for more than
48 hours).td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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rier to early mobilization [17]. Although mobilization in
the presence of femoral arterial catheters is safe [18,19], de-
livery of CRRT via femoral catheters precludes hip flexion
in practice and research [3]. Researchers in several recent
studies have reported data on the safety and feasibility of
mobilization in patients with femoral catheters (including
arterial, venous and haemodialysis) [5,18-20], but none
have reported CRRT data specifically during mobilization.
Maintenance of the filter circuit is important, as premature
disconnection results in loss of blood, increased nursing
workload and increased costs [21]. Filter life is also an im-
portant indicator of CRRT efficacy [22]. The specific effects
of mobilization on the vascular catheter, circuit pressures,
fluid dynamics and blood flow in patients receiving CRRT
via dual-lumen femoral vascular catheters are uncertain.
Therefore, our objective in this study was to test the safety
and feasibility of mobilization in ICU patients with femoral
vascular catheter placement during CRRT.
Material and methods
Design, setting and participants
This prospective cohort study (Australian and New Zealand
Clinical Trials Registry Number ACTRN12611000733976)
was conducted between August 2011 and August 2012 in
the 21-bed tertiary ICU at Monash Medical Centre and the
14-bed tertiary ICU at Dandenong Hospital, both of which
are in Victoria, Australia. In the absence of empirical data
on which to base the sample size, a convenience sample
of 40 participants was selected. The institutional ethical
review board responsible for both sites (Monash Health,
Melbourne, Australia) approved the study at both sites. In-
formed consent was obtained from participants or their sur-
rogate decision-makers. Participants were eligible if admitted
to the ICU with the insertion of a vascular catheter for CRRT.
Patients were excluded if they were receiving sustained low-
efficiency dialysis or CRRT via permanent vascular access.
Exclusion and cessation criteria
Passive group patients were ineligible to participate in
the intervention if they met any of the following criteria:
 Extreme agitation or confusion (Richmond
Agitation–Sedation Scale +3 or +4 [23])
 Heart rate >160 or <40 beats/min or new arrhythmia
 Limb movement restricted for reasons other
than the presence of the vascular catheter
Low-level or high-level group patients were ineligible
for the reasons listed above or if they met any of the fol-
lowing criteria:
 Mean arterial blood pressure <60 mmHg or
>120 mmHg >10 μg/min noradrenaline (or equivalent)
 Fraction of inspired oxygen >0.6 and/or partial
pressure of oxygen <65 mmHg
 Peripheral oxygen saturation <85% or drop >10%
from resting level
 Respiratory rate >35 breaths/min
 Temperature >38.5°C
 Drowsy, unable to follow commands
 New-onset chest pain with suspected cardiac cause
The intervention was ceased if these criteria were met
without recovery in 2 minutes. Any CRRT alarms during
the intervention were assessed and responded to by the
bedside nurses. The intervention was then continued in
consultation with the nurse after troubleshooting of the
machine alarms was complete. If the CRRT alarms could
not be resolved by the bedside nurse within 2 minutes
and were thought to be associated with the intervention,
mobilization was ceased.
Procedure
Routine baseline data on the primary outcomes were
recorded prior to study recruitment for 19 additional pa-
tients to monitor the Hawthorne effect. Participants were
screened by treating ICU physiotherapists daily on week-
days. CRRT was generally delivered via continuous veno-
venous haemodiafiltration (CVVHDF) using Prismaflex
ST100 filters (Gambro Lundia AB, Lund, Sweden) at a
dialysate rate of 20 ml/kg/h, a replacement fluid rate of
15 ml/kg/h (delivered after the filter) and an effluent fluid
removal rate of 50 to 100 ml/h with primarily Lactasol™ or
Hemosol™ (Gambro Lundia AB).
Intervention
The movement on vascular catheter evaluation (MOVE)
intervention was delivered by senior treating ICU physio-
therapist(s) at three different levels (passive, low-level
physical function, high-level physical function), depending
on the participant’s ability. No training of staff was re-
quired to deliver the intervention, as mobilization activ-
ities formed part of usual care in the study sites. A single
intervention of 20 minutes (five positions for 4 minutes
each) was delivered to reflect an effective clinical treat-
ment dosage [9]. Prior to the intervention, investigators
checked vascular catheter security and suturing. The
following were the three intervention levels and details:
1. Passive: (a) Unable to participate (for example,
sedation, low Glasgow Coma Scale score, severe
weakness); (b) supine, sustained hip flexion (45°),
supine, repeated-movement hip flexion (45°), supine.
2. Low-level: (a) Able to participate, assessed as likely
unable to stand; (b) supine, repeated hip flexion
(45°), supine, sitting on the edge of the bed, supine.
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being able to stand (with or without assistance); (b)
supine, standing, marching on the spot, sitting on
the edge of the bed, supine.
Measurement
The following data were recorded on the day of interven-
tion and daily thereafter for at least three further filters,
until the intervention vascular catheter was removed or
the patient was discharged from the ICU, whichever
occurred first: age, sex, severity of illness (based on Acute
Physiology and Chronic Health Evaluation (APACHE II
and III) scores), mechanical ventilation, vascular catheter
type, site, daily pathology (for example, platelets, inter-
national normalized ratio (INR), activated partial thrombo-
plastin time (aPTT)), non-intervention-related position
changes (daily) and sedation and delirium scores. Sedation
and delirium were assessed using the Richmond Agitation–
Sedation Scale [23] and the Confusion Assessment Method
for the ICU [24,25].
The primary outcome measure was the occurrence of
adverse events during or after interventions, defined
a priori as the following:
 Vascular catheter dislodgement (assessed by visual
inspection)
 Filter circuit clotting or disruption (assessed by
circuit disconnection)
 Bleeding, haematoma at the vascular catheter site
(assessed by visual inspection and medical and
nursing documentation)
 Clinical suspicion of thrombosis (vascular
observations recorded every 2 hours
postintervention, medical documentation, radiology
for ultrasound referral)
 Arrhythmia (assessed by visual inspection of
electrocardiogram and medical documentation)
The following secondary outcome measures were used:
 Filter life (measured from filter commencement to
disconnection as documented by nursing staff (1:1 ratio))
 Intervention feasibility (measured by filter alarm
rates, pressures (access, return, transmembrane),
blood flow recorded each minute from the digital
output screen (Prismaflex))
Additional secondary measures included nursing work-
load and nurses’ concerns about filter disconnection (see
Additional file 1 for more details on methods and results).
Data analysis
The reason for cessation of filtration was recorded
(either elective or not), and elective cessation filters wereexcluded from the filter life analyses. Descriptive statis-
tics (median (IQR) or mean (SD)) were calculated as ap-
propriate (Kolmogorov-Smirnov test). Linear regression
analyses clustered by individual participant (to account
for multiple filters within individual participants) and
robust variance estimates were used to compare filter
lifespan for filters where the participant was exposed to
an intervention as opposed to filters where no interven-
tion was provided. The number of filters that partici-
pants received was adjusted for by including the filter
numbers (first filter = 1, second filter = 2 and so forth) in
an interaction term with the intervention term in the
analysis. Subgroup analyses separating data on the basis
of vascular catheter site (femoral vs nonfemoral) and
intervention group (passive vs low-level vs high-level)
were performed. Sensitivity analyses were conducted to
determine whether differences in aPTT, INR, platelets,
non-intervention-related position changes (frequency),
APACHE III scores and number of CRRT alarms during
intervention influenced the primary analyses. In these
sensitivity analyses, covariates were added to the regres-
sion models to examine their influence on the statistical
significance of the MOVE intervention. Missing data
were excluded listwise from analyses. Statistical analysis
was performed using IBM SPSS Statistics™ 20 version
20.0.0 (SPSS, Chicago, IL, USA) and STATA/SE version
12 (StataCorp LP, Austin, TX, USA). P < 0.05 was ac-
cepted as the level of statistical significance.Results
In the analyses, 34 patients were included and 1 was
excluded (Figure 1). Recruitment was ceased without six
high-level intervention participants, as those meeting
the relevant inclusion criteria were present in much
lower than anticipated numbers. No patients died in the
ICU. Twenty-three (17.2%) of one hundred thirty-four
femoral filters and fourteen (23.0%) of sixty-one nonfe-
moral filters were excluded from filter life analyses
(elective cessation). The sample was broadly representa-
tive of a general ICU cohort (Table 1). None of the filters
were planned for disconnection on the intervention day.
The vascular catheter was sutured upon site check prior
to the intervention in all patients. Eleven, sixteen and six
patients received a single passive, low-level or high-level
intervention, respectively (Figure 1), with mean (SD)
treatment duration of 19 (±3) minutes. The median
(IQR) days of follow-up was 4 (2 to 6).Safety
No adverse events occurred during or following the
interventions. One participant had a pulmonary artery
catheter placed (in the low-level group), and no arrhyth-
mias were associated with the interventions.
Figure 1 Flowchart of participants through the study. IJ: Internal jugular; SC: Subclavian.
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Mean filter life at the time of the intervention was
19.5 hours (SD ±13.8), with no difference observed be-
tween femoral and nonfemoral filters (21.6 (15.1) hours
vs 15.3 (9.9) hours, P = 0.45). Filters lasted for a mean of
17.4 (SD 12.7) hours after intervention. Intervention fil-
ters lasted longer than nonintervention filters (regression
coefficient = 13.8, robust 95% confidence interval (CI) =
5.0 to 22.6, P = 0.003). A difference was also found in
the femoral filter subgroup (regression coefficient = 15.7,
robust 95% CI = 4.6 to 26.7, P = 0.008), but not in the
nonfemoral access filter subgroup (regression coefficient =
9.2, robust 95% CI = −6.0 to 24.4, P = 0.20) (Figure 2).
An increasing effect of the MOVE intervention on fil-
ter life was evident in the higher the number of previous
filters at the time of intervention (filter number ×MOVE
interaction effect: regression coefficient = 3.5, robust 95%
CI = 0.3 to 6.6, P = 0.03). The effect of MOVE was
approximately a 3-hour increase in filter life per filter
already placed in the patient.
A higher number of daily position changes was associ-
ated with higher filter life in the overall cohort (regressioncoefficient = 2.0, robust 95% CI = 0.6 to 3.5, P = 0.007)
and the femoral filter subgroup (regression coefficient =
2.0, robust 95% CI = 0.5 to 3.6, P = 0.01), but not in the
nonfemoral filter subgroup (regression coefficient = 1.9,
robust 95% CI = −1.7 to 5.4, P = 0.27) (Table 2). Alarm
frequency during interventions was associated with a
shorter filter life in the overall cohort (regression coeffi-
cient = −3.1, robust 95% CI = −5.0 to −1.2, P = 0.003) and
the femoral filter subgroup (regression coefficient = −7.4,
robust 95% CI = −13.0 to −1.8, P = 0.01), but, again, not
in the nonfemoral filter subgroup (regression coeffi-
cient = −2.3, robust 95% CI = −4.6 to 0.0, P = 0.05). The
passive intervention had a significant role in increasing
filter life in the femoral filter subgroup, but only INR
and aPTT were associated with filter life in the nonfe-
moral filter subgroup (Table 2). There were no signifi-
cant differences in aPTT, INR, platelet count or rate of
non-intervention-related position changes between the
femoral filter intervention and nonintervention groups
(Additional file 2). Addition of these covariates to the
sensitivity analyses did not influence the effect of the
MOVE intervention.
Table 1 Demographic and clinical details of the sample at the time of the interventiona
Variable Baseline group (n = 19) Intervention group (n = 33) Femoral (n = 23) Nonfemoral (n = 10)
Age, yr 63.6 (13.6) 63.7 (14.8) 63.7 (14.1) 63.6 (17.2)
Sex, % male 79% 61% 65% 50%
BMI 28.0 (5.1) 29.3 (10.6) 31.7 (11.2) 23.9 (7.0)
Diagnosis, %
Cardiogenic shock/cardiac 26% 33% 30% 40%
Septic shock/sepsis/MOF 47% 43% 44% 40%
Renal/metabolic/electrolyte 21% 15% 17% 10%
Haemorrhagic shock/haematoma 0% 9% 9% 10%
Vascular surgery 5% 0% 0% 0%
APACHE II score – 26.1 (7.2) 25.7 (6.8) 26.9 (8.2)
APACHE III score 98.3 (26.9) 93.8 (24.9) 91.1 (23.1) 100.0 (29.1)
ICU length of stay, days 10.2 (6.9) 15.0 (10.0) 15.4 (9.3) 14.1 (11.8)
MV, % 74% 76% 74% 80%
MV hours, median (IQR) 78 (0 to 153) 76 (0 to 267) 89 (0 to 295) 63 (30 to 190)
Siteb, %
Femoral 63% 70% 100% 0%
Internal jugular 37% 21% 0% 70%
Subclavian 0% 9% 0% 30%
Catheter typec, n (%)
Dolphin Protect 13 (68%) 19 (58%) 13 (57%) 6 (55%)
Niagara™ 5 (26%) 9 (27%) 7 (30%) 2 (18%)
Arrow-Howes™ 1 (5%) 5 (15%) 3 (13%) 1 (9%)
Intervention filter type, %
Prismaflex ST100 N/A 94% 91% 100%
Intervention filter anticoagulation, %
Heparin N/A 27% 26% 30%
Citrate N/A 6% 4% 10%
Saline N/A 0% 0% 0%
Regional circuit N/A 52 48% 60%
Other N/A 3% 4% 0%
Nil N/A 12% 17% 0%
FBE on intervention filter, median (IQR)
Hb, g/dl N/A 89 (85 to 94) 88 (81 to 91) 93 (90 to 103)
Platelets, 103 U/L N/A 125 (60 to 200) 121 (59 to 174) 179 (60 to 252)
INR N/A 1.1 (1.1 to 1.4) 1.2 (1.1 to 1.4) 1.1 (1.1 to 1.3)
aPTT N/A 39 (34 to 52) 40 (34 to 55) 34 (33 to 44)
RASS, median (IQR) N/A −1 (−4 to 0) −2 (−4 to 0) −1 (−1 to 0)
CAM-ICU positive, % N/A 42% 39% 50%
Hospital LOS in days, median (IQR) 23 (9 to 31) 31 (21 to 57) 29 (21 to 57) 37 (15 to 57)
Hospital mortality, % 42% 15% 17% 10%
aaPTT, Activated thromboplastin time; BMI: Body mass index; CAM-ICU: Confusion Assessment Method for the ICU; FBE: Full blood examination; Hb: Haemoglobin;
ICU: Intensive care unit; INR: International normalized ratio; IQR: Interquartile range; LOS: Length of stay; MOF: Multiorgan failure; MV: Mechanical ventilation; N/A:
Not applicable; RASS: Richmond Agitation–Sedation Scale. bFemoral (14 in right, 9 in left), intrajugular (6 in right, 1 in left) and subclavian (3 in left, 1 in right).
cDolphin Protect (13-French gauge, 25 cm; Gambro, Hechingen, Germany), Niagara™ (13.5-French gauge; Bard Access Systems, Salt Lake City, UT, USA), Arrow-Howes™
triple-lumen (13-French, 20 cm; Teleflex, Research Triangle Park, NC, USA). Data are mean (SD) unless otherwise specified. Percentages may not add up to 100% due
to rounding.
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Figure 2 Comparison of femoral filter life. Preintervention filters are those that patients had prior to recruitment and intervention. Intervention
filters are those in place during the time the intervention took place. Postintervention filters are those placed after the intervention filter.
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No filter alarms sounded during interventions on 20 occa-
sions (61% of the time). The machine alarmed a median of
0.0 (interquartile range = 0 to 2, range = 0 to 10) times
during interventions. No differences in access, return or
transmembrane (TM) pressures were observed in any
group between the final and first phases (Additional
file 3). There was a drop in access pressure during the
sitting on edge of bed phase accompanied by a rise in
TM pressure in the low-level group. There was an
increase in access, return and TM pressures during the
standing and marching phases in the high-level group,
which returned to preintervention pressures during the
final period (Additional file 3).
Discussion
Mobilization of patients with femoral vascular catheters re-
ceiving CRRT in the ICU was safe and feasible. The inter-
vention did not result in vascular catheter dislodgement,
haematoma or bleeding, and there were no detectable clin-
ical sequelae, including suspected thrombosis or filter cir-
cuit disruption. Average pressures did not approach circuit
failure definitions (TM pressure >250 mmHg and access
pressure >200 mmHg [26]) in any intervention group.
These findings have significant implications for clinical
practice situations where patients on CRRT are unneces-
sarily restrained from movement because of the perceived
importance of these restrictions to maintaining filter pa-
tency and filter life and reducing mortality [27]. Interrup-
tions in CRRT impact the dose of therapy delivered as well
as clinical outcomes [27]. Testing mobilization during
CRRT is critical, given that the opportunity to mobilize offCRRT can be minimal (minimum 16 hours required to
maintain urea and creatinine, with a median time of
3 hours daily off filtration [22]), whereas time off CRRT
can occur when it is impractical to mobilize (for example,
overnight). Historically, contraindications to mobilization
arose during an era of rigid medical plastics, which were
associated with greater potential for vascular damage with
movement. Although advances in materials [28] have
resulted in more malleable catheters, manufacturers do not
provide mobility specifications. These findings underscore
the importance of empirically testing practices that have
been accepted for many years. The presence of femoral
vascular catheters for CRRT is a significant barrier to the
delivery of early mobilization in the ICU [3,17], as demon-
strated in this study, where nurses’ concerns about circuit
disconnection rose significantly when they were informed
that mobilization was to occur. Few researchers have re-
ported mobilization data regarding patients with femoral
catheters [5,18,29,30]. Although no catheter-related ad-
verse events occurred during mobilization with femoral
catheters in two of these previous studies [18,30], only six
patients in one cohort received an intervention with CRRT
femoral catheters in situ [18] and the mobility intervention
delivered to patients with femoral dialysis catheters was
not specified in the other [30]. In neither study did the
investigators report filter life or whether the intervention
occurred during CRRT. Our present study is the first in
which the safety and feasibility of mobilizing patients
undergoing CRRT were prospectively evaluated.
It was important to test the safety of hip flexion, as key
early mobilization trials have included passive range of
motion [8] and cycle ergometry [9] as rehabilitation
Table 2 Subgroup and sensitivity analyses of filter life and possible confoundersa
Group Factors Regression coefficient (robust 95% CI) P value
Baseline (n = 19) INR 0.8 (−1.4 to 3.0) 0.44
aPTT 0.1 (−0.3 to 0.5) 0.63
Platelets 0.0 (0.0 to 0.1) 0.09
Positional changes 1.2 (−0.4 to 2.9) 0.13
APACHE III −0.1 (−0.3 to 0.0) 0.09
Overall cohort (MOVE intervention) (n = 33) MOVE intervention 13.8 (5.0 to 22.6) 0.003b
Overall subgroup and sensitivity analyses Passive movements 20.0 (5.4 to 34.6) 0.01b
SOEOB 5.8 (−10.7 to 22.3) 0.46
MOS 18.3 (−1.3 to 37.9) 0.06
INR 9.3 (−2.0 to 20.5) 0.10
aPTT 0.0 (−0.2 to 0.2) 0.86
Platelets 0.0 (−0.1 to 0.0) 0.10
Positional changes 2.0 (0.6 to 3.5) 0.007b
APACHE III 0.1 (0.0 to 0.3) 0.02b
Alarms −3.1 (−5.0 to −1.2) 0.003b
Femoral subgroup (n =23) MOVE intervention 15.7 (4.6 to 26.9) 0.008b
Femoral subgroup and sensitivity analyses Passive movements 20.0 (5.4 to 34.6) 0.01b
SOEOB 8.5 (−20.6 to 37.7) 0.51
MOS 20.5 (−19.9 to 60.9) 0.16
INR 7.6 (−4.9 to 20.0) 0.22
aPTT −0.1 (−0.2 to 0.1) 0.38
Platelets 0.0 (−0.1 to 0.0) 0.29
Positional changes 2.0 (0.5 to 3.6) 0.01b
APACHE III 0.6 (−0.1 to 0.2) 0.42
Alarms −7.4 (−13.0 to −1.8) 0.01b
Nonfemoral subgroup (n = 10) MOVE intervention 9.2 (−6.0 to 24.4) 0.20
Nonfemoral subgroup and sensitivity analyses Passive movements N/A –
SOEOB 1.0 (−12.8 to 14.8) 0.86
MOS 20.6 (−23.3 to 64.4) 0.23
INR 26.4 (7.5 to 45.3) 0.01b
aPTT 0.5 (0.1 to 0.9) 0.03b
Platelets −0.1 (−0.1 to 0.0) 0.08
Positional changes 1.9 (−1.7 to 5.4) 0.27
APACHE III 0.2 (0.0 to 0.5) 0.05
Alarms −2.3 (−4.6 to 0.0) 0.05
aAPACHE III: Acute Physiology and Chronic Health Evaluation III; aPTT: Activated partial thromboplastin time; CI: Confidence interval; INR: International normalized
ratio; MOS: Marching on the spot; MOVE: Movement on vascular catheter evaluation intervention; N/A: Not applicable; SOEOB: Sitting on edge of bed. Electively
ceased filters were excluded from analysis. Twenty-three (17.2%) of one hundred thirty-four femoral filters and fourteen (23.0%) of sixty-one nonfemoral filters
were excluded from the filter life analyses, as they were electively ceased. Units of measurement for filter life are hours. Position changes are measured as number
per day. Alarms are the number of alarms during the intervention session. bStatistically significant difference.
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be precluded from early mobilization on the basis that a
vascular catheter or CRRT is in situ. It should be noted
that the ability of patients undergoing CRRT to stand and
march appears to be limited. In this study, we were able to
recruit only three participants with femoral catheters whowere able to perform these activities in 12 months in two
ICUs. Talley and colleagues found that only 1.8% of their
cohort were able to stand and/or ambulate with assistance
[5], although the functional benefit of walking in the ICU
compared to standing, marching on the spot or sitting on
the edge of the bed is unclear. This is likely due to high
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51% [5,31], with 28-day mortality of 41% [32], though few
studies have investigated functional and quality-of-life out-
comes in this population [33].
Another key finding, which requires further empirical
testing given the small sample size in this study, is
that mobilization extended filter life, which has clinical,
cost and potential survival implications. Increasing filter
life could reduce nursing workload, costs, blood loss
and infection risk [5]. Reducing flow stasis has been
suggested to improve filter life [20], and, as exercise
increases blood volume flow in healthy individuals
[34,35], the mechanism of mobilization is plausible. Al-
though few researchers have investigated blood flow and
immobilization in critical illness, it has been hypothesized
that inactivity-related vascular injury, venous pooling and
microvascular dysfunction increase thromboembolism
risk [36,37]. There are published data demonstrating that
exercise increases blood volume flow in healthy individ-
uals [34,35]. It is therefore plausible that increasing blood
flow could reduce thrombosis in critically ill patients who
are undergoing continuous renal replacement therapy.
The results of the sensitivity analyses in our present study
support this hypothesis, as passive hip flexion and pos-
itional changes improved filter life in the femoral sub-
group, but not in the nonfemoral subgroup. Because
mean peak blood flow is usually higher in the subclavian
and internal jugular veins than in the femoral veins
[38,39], we hypothesize that catheters sited in the femoral
veins may be more susceptible to the effects of stasis with
immobility. This hypothesis is supported by the results of
our sensitivity analyses, which demonstrate that the
MOVE intervention and position changes were not
significantly associated with filter life (but that INR and
aPTT were) in the nonfemoral subgroup. There
are also potential trends in the data that may be more
thoroughly explored with larger sample sizes; for ex-
ample, large regression coefficients that were not statis-
tically significant were seen for marching on the spot
and INR in the overall cohort sensitivity analyses. It is
possible that different results would be found in patients
undergoing continuous venovenous haemofiltration ra-
ther than CVVHDF, although in Australia the majority
of CRRT delivery is via CVVHDF [31]. Generalizability
of the results to other ICUs may be influenced by vari-
ation in CRRT practices, although filtration practices in
the two centres in this study were largely reflective of
Australasian ICUs.
Limitations
This study is limited by its single-health-service design,
although it was conducted at two sites. The sample size
was small (albeit one of the largest to date in this field
reported in the literature). The results may have beeninfluenced by sampling error; however, it should be
noted that the characteristics of the study sample were
largely consistent with characteristics of the routine
baseline sample. Large multicentre studies are warranted
to confirm our findings and further strengthen our
conclusions, in particular those pertaining to filter life.
Delivery of CRRT was not standardized, and the filter
failure criteria were not specified a priori. The reason
for filter cessation was not always recorded and could
have been biased by nursing staff, although the average
filter life of the nonintervention filters during the study
period was the same as that of the baseline filters and
less than half the nursing staff knew that their patients
had mobilized during CRRT. Despite this, the main pre-
viously reported determinants of filter life were compar-
able between femoral and nonfemoral filters. A single
intervention session was delivered to each patient, and it
was not possible to examine possible dose–response
relationships between duration of mobilization and filter
life, because the intervention duration was standardized.
In future studies, researchers could investigate a possible
dose–response relationship between mobilization and
filter life.
Conclusions
Mobilization during CRRT via a vascular catheter in pa-
tients who are critically ill is safe and may increase filter
life. Given the established benefit of early mobilization
in the critical care population, early mobilization should
be considered as part of the management of patients
undergoing CRRT. Stasis secondary to immobility may
contribute to the life of the haemodiafiltration circuit.
Large multicentre studies are warranted to confirm the
findings of our study and further strengthen our conclu-
sions, particularly those pertaining to filter life.
Key messages
 Early mobilization improves health outcomes
following admission to the ICU, including
ventilation duration, length of stay and delirium.
However, patients undergoing CRRT are frequently
precluded from participation in early mobilization
because of concerns about catheter safety and filter
circuit patency. There are no previous studies in
which researchers have reported data on filter
circuit patency and filter life associated with early
mobilization.
 This study is the first in which filter life data were
recorded for patients undergoing CRRT via a
vascular catheter in the ICU. Mobilization was
found to be safe and associated with no adverse
events, and we found an increase in filter life in the
group with femoral catheters.
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http://ccforum.com/content/18/4/R161 Our presently reported work will have a significant
impact on clinical medicine, as it provides empirical
data suggesting that restrictions on mobilization
imposed on patients undergoing CRRT are
detrimental to filter life, which has a direct impact
on the success of the therapy.
 Our present research suggests that stasis of blood
influences filter life, which may be a significant
contributor to ICU morbidity and mortality in this
population. This concept remains unexplored in the
ICU literature.
 Our findings have significant implications for the
clinical management and morbidity of patients
undergoing CRRT in critical care.
Additional files
Additional file 1: Nursing workload and nursing concern about
filter disconnection. Includes methods and results of the effect of the
intervention on nursing workload and nursing perception of likelihood of
filter circuit discontinuation.
Additional file 2: Characteristics of filters by intervention group
and access site. Includes clinical data of baseline, intervention and
nonintervention filters (femoral and nonfemoral).
Additional file 3: Mean CVVHDF filter parameters during
intervention in patients with femoral catheters. Includes variations in
access and transmembrane pressure during the three levels of
intervention: passive (hip flexion), low-level (hip flexion and sitting on
edge of bed) and high-level (sitting on edge of bed, standing and
marching on spot).
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